
BREAKTHROUGH: Nobel Prize Molecule DOUBLES Lifespan in Groundbreaking Study — Big Pharma Doesn't Want You to Know
A 2012 Paris study on C60 fullerenes produced shocking results: treated subjects lived 90% longer with zero tumors, while Big Pharma buried the findings.










